Pacira BioSciences, Inc. (PCRX)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -99,560 | 41,955 | 15,909 | 41,980 | 145,523 |
| Revenue | US$ in thousands | 700,966 | 674,978 | 666,823 | 541,533 | 420,830 |
| Net profit margin | -14.20% | 6.22% | 2.39% | 7.75% | 34.58% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $-99,560K ÷ $700,966K
= -14.20%
The net profit margin of Pacira BioSciences, Inc. has shown varying trends over the years based on the provided data.
- In December 2020, the net profit margin was reported at a healthy 34.58%, indicating that the company was able to convert a significant portion of its revenue into profits.
- However, by December 2021, the net profit margin decreased to 7.75%, suggesting a decline in profitability.
- The trend continued into December 2022, with the net profit margin further dropping to 2.39%, indicating challenges in maintaining profitability.
- There was a slight improvement by December 2023, as the net profit margin increased to 6.22%, but it still remained below the levels seen in 2020.
- December 2024 saw a significant negative turn, with the net profit margin falling to -14.20%, indicating that the company may have incurred losses during that period.
Overall, the trend in the net profit margin of Pacira BioSciences, Inc. shows both positive and negative fluctuations, reflecting changes in the company's ability to generate profits relative to its revenue over the years.
Peer comparison
Dec 31, 2024